Article info

Download PDFPDF
Extended report
Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis

Authors

  1. Correspondence to Professor Dominique L Baeten, Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Meibergdreef 9, Amsterdam 1105 AZ, The Netherlands; d.l.baeten{at}amc.uva.nl
View Full Text

Citation

Paramarta JE, De Rycke L, Heijda TF, et al
Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis

Publication history

  • Accepted October 11, 2012
  • First published November 8, 2012.
Online issue publication 
April 20, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.